The purpose of the meeting was to raise awareness and commitment to the development and early implementation of a global program for surveillance of Antimicrobial Resistance (AMR) in human health. The meeting focused on strategies to improve and implement local and global surveillance of antimicrobial resistance, with a particular emphasis on resistance to antibiotics.
Key objectives of the meeting
- Obtain high level commitment to build capacities needed for appropriate AMR surveillance, as part of the Global Action Plan.
- Discuss ways forward to develop and implement a global program for surveillance of AMR in human health, with the purpose of estimating magnitude and burden, guide interventions, monitor trends and assess impact of interventions.
- Agree on international collaboration to build a global program for surveillance of AMR in human health, starting with an early implementation phase of agreed surveillance standards and principles for collaboration.
Outputs of the meeting
- An Outcome Statement indicating commitment to address AMR surveillance through national action and to develop and implement a global program for surveillance of AMR in human health, promoting a coherent multilateral and multi-sectorial approach.
- A Roadmap for the development of global AMR surveillance.
- The Launch of International Collaboration to build global AMR surveillance, the first step being to agree to an early implementation phase to test the feasibility of collecting and sharing data according to the proposed surveillance standards.
Participants
- 30-35 selected Member States, representing all six WHO regions
- Representatives of working groups linked to the Global Technical Consultations
- Delegates from World Organisation for Animal Health (OIE) and the Food and Agriculture Organisation of the United Nations (FAO)
- WHO representatives of Geneva and regional offices
- Representatives from the Government of Sweden and key medical institutions
The number of participants was limited and reserved for invited delegates only.